Duchenne-izomdisztrófia: vizsgálatok itt: Spanyolország
15 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
- Where
- Barcelona, Madrid, Seville
- Életkor
- 7 év to 16 év
- People
- 70 worldwide
- Run by
- Avidity Biosciences, Inc.
See details and how to joinNCT07587242 - 3. fázisTaking peopleStudy in which all the patients take the same investigational drug with the aim of evaluate the long-term safety, tolerability, and efficacy of GIVINOSTAT in all the patients affected with Duchenne Muscolar Dystrophy who have been already treated in one of the GIVINOSTAT studies in the past
- Where
- Barcelona, Esplugues de Llobregat, Sevilla, Valencia
- Életkor
- Up to 64 év
- People
- 207 worldwide
- Run by
- Italfarmaco S.p.A.
See details and how to join2023-504520-26-00 · EU 2023-504520-26-00 - 2/3. fázisTaking peopleA Clinical Study to Assess Safety, Efficacy and Pharmacodynamic Profile of GNT0004 in Duchenne Muscular Dystrophy
- Where
- Esplugues de Llobregat, Valencia
- Életkor
- 6 év to 10 év
- People
- 77 worldwide
- Run by
- Genethon
See details and how to joinNCT07856329 · EU 2023-505187-11-00 - 3. fázisTaking peopleA Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
- Where
- Barcelona, Esplugues de Llobregat, Valencia
- Életkor
- 7 év to 11 év
- People
- 80 worldwide
- Run by
- Solid Biosciences Inc.
See details and how to joinNCT07160634 · EU 2025-522949-22-00 - 2. fázisCsak meghívásosOpen-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
- Where
- Barcelona, Donostia / San Sebastian, Valencia
- People
- 260 worldwide
- Run by
- Edgewise Therapeutics, Inc.
See details and how to joinNCT06066580 - 1/2. fázisTaking peopleA Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44
- Where
- Barcelona, Esplugues de Llobregat
- Életkor
- 4 év to 20 év
- People
- 24 worldwide
- Run by
- Entrada Therapeutics, Inc.
See details and how to joinNCT07037862 · EU 2024-517584-23-00 - 1/2. fázisTaking peopleA Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45
- Where
- Barcelona, Esplugues de Llobregat
- Életkor
- 4 év to 20 év
- People
- 24 worldwide
- Run by
- Entrada Therapeutics, Inc.
See details and how to joinNCT07038824 · EU 2024-517499-39-00 - 3. fázisTaking peopleEfficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
- Where
- Esplugues de Llobregat, Valencia
- Életkor
- 9 év to 17 év
- People
- 138 worldwide
- Run by
- Italfarmaco
See details and how to joinNCT05933057 · EU 2023-503521-19-00 - 2. fázisCsak meghívásosAn Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular Dystrophy
- Where
- Sevilla
- Életkor
- 4 év to 64 év
- People
- 18 worldwide
- Run by
- BioMarin Pharmaceutical
See details and how to joinNCT07573631 · EU 2024-511656-41-00 - 2. fázisNot yet taking people in SpanyolországLong-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the Safety and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE)
- Where
- Barcelona, Esplugues de Llobregat
- Életkor
- 4 év to 20 év
- People
- 80 worldwide
- Run by
- Entrada Therapeutics, Inc.
See details and how to joinNCT07682129 · EU 2025-525124-10-00 - 3. fázisTaking peopleA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study with an Open-Label Extension to Evaluate the Efficacy and Safety of Intravenous AOC 1044 (delpacibart zotadirsen) for the Treatment of DMD with Gene Mutations Amenable to Exon 44 Skipping
- Where
- Esplugues de Llobregat, Madrid, Sevilla
- Életkor
- Up to 17 év
- People
- 42 worldwide
- Run by
- Avidity Biosciences Inc.
See details and how to join2025-523087-20-00 · EU 2025-523087-20-00 - No phaseTaking peopleNatural History of Duchenne Muscular Dystrophy
- Where
- Esplugues de Llobregat, Valencia
- Életkor
- 4 év to 9 év
- People
- 220 worldwide
- Run by
- Genethon
See details and how to joinNCT03882827 - 3. fázisCsak meghívásosA Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
- Where
- Esplugues De Llobregat, Valencia
- Életkor
- Up to 64 év
- People
- 400 worldwide
- Run by
- Sarepta Therapeutics, Inc.
See details and how to joinNCT05967351 · EU 2023-505043-39-00 - 2/3. fázisTaking peopleGivinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
- Where
- Barcelona, Esplugues de Llobregat, Seville, Valencia
- Életkor
- 7 év and over
- People
- 206 worldwide
- Run by
- Italfarmaco
See details and how to joinNCT03373968 - No phaseCsak meghívásosEffectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies.
- Where
- Málaga
- Életkor
- 5 év to 20 év
- People
- 12
- Run by
- University of Malaga
See details and how to joinNCT06363526